Qfitlia

Active Ingredient(s): Fitusiran Sodium
FDA Approved: * March 28, 2025
Pharm Company: * GENZYME CORP
Category: Blood Clotting (Hemostasis)
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Qfitlia 20 mg/.2ml Subcutaneous Injection, Solution
NDC: 58468-0347
Labeler:
Genzyme Corporation
Qfitlia 50 mg/.5ml Subcutaneous Injection, Solution
NDC: 58468-0348
Labeler:
Genzyme Corporation